Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer.

ABSTRACT:

SUBMITTER: Antonarakis ES 

PROVIDER: S-EPMC6254684 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature